The US Food and Drug Administration recently announced the launch of a regulatory incentive program pilot program, the ...

Cognition Therapeutics shares rose 30% pre-market after the FDA confirmed its Phase 3 trial for Alzheimer's drug Zervimesine.

The U.S. Food and Drug Administration has approved Insmed's oral drug for a type of lung disease, the company said on Tuesday ...

H-D Feminine Health, announces it has initiated the first randomized, placebo-controlled, double-blinded Phase 3 clinical trial cleared to proceed by the U.S. Food and Drug Administration (FDA) to ...

Indoco Remedies receives US FDA final approval for rivaroxaban tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg: Our Bureau, Mumbai Wednesday, August 13, 2025, 13:45 Hrs [IST] Indoco R ...

Mumbai: Indoco Remedies Ltd. has received final approval from the US Food and Drug Administration (USFDA) for the Company's ...

Senores Pharmaceuticals acquires two ANDAs from Teva Pharmaceuticals USA Inc., expanding its US market presence.

Monopar Therapeutics Inc. ('Monopar” or the 'Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, ...

Ahmedabad: Senores Pharmaceuticals Limited, through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA, has ...

Zydus Lifesciences exceeded expectations in the June quarter with a 6% revenue growth to ₹6,573 crore and a net profit of ...

The FDA has agreed to fast-track its review of gepotidacin, an oral antibiotic already approved for urinary tract infections, ...

Dr. Tweezer-Zaks Transitions from the Company’s Board of Directors to Lead Medical Strategy Following Positive Phase 3 ...